Reductions in renin‐angiotensin system inhibitors following hospitalization for heart failure

Reductions in renin‐angiotensin system inhibitors following hospitalization for heart failure

Abstract Aims Limited data are available that evaluate the efficacy of renin‐angiotensin system inhibitor (RASI) dose‐reduction in older adults with heart failure with reduced ejection fraction following a heart failure hospitalization. Methods and results We examined a 5% random sample of Medicare...

Full description

Saved in:

Bibliographic Details
Main Authors:	Parag Goyal, Ligong Chen, Jennifer D. Lau, Robert S. Rosenson, Emily B. Levitan
Format:	Article
Language:	English
Published:	Wiley 2024-12-01
Series:	ESC Heart Failure
Subjects:	Cardiac disease Heart failure
Online Access:	https://doi.org/10.1002/ehf2.14953
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Angiotensin Receptor‐Neprilysin Inhibitor Is Associated With Improved Cardiac Autonomic Function in Heart Failure
by: Andreas A. Boehmer, et al.
Published: (2024-08-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

Sodium Zirconium Cyclosilicate for Renin–Angiotensin–Aldosterone System Inhibitor Optimization in Patients with Heart Failure with Reduced Ejection Fraction: A Retrospective Analysis
by: Rhys Williams, et al.
Published: (2024-11-01)

Effect of combination antihypertensive therapy, including renin-angiotensin-aldosterone system inhibitors, on oxidative stress and arterial remodeling in hypertensive patients with heart failure with preserved ejection fraction
by: Z. M. Akhilgova, et al.
Published: (2021-06-01)

Heart failure
by: James A. Ker
Published: (2010-06-01)

Impact of SGLT-2 Inhibitors on Biomarkers of Heart Failure
by: Dana Darwish, et al.
Published: (2025-06-01)

Comparative effects of renin-angiotensin-aldosterone system modulators on right heart function and prognosis in patients with severe systolic chronic heart failure
by: K. G. Adamyan, et al.
Published: (2012-12-01)

EFFECT OF ACE INHIBITOR AND RECEPTOR ANTAGONIST OF TYPE 1 ANGIOTENSIN II ON HEMODYNAMICS AND MORPHO-FUNCTIONAL PARAMETERS OF THE HEART IN PATIENTS WITH HEART FAILURE ON A BACKGROUND OF CORONARY HEART DISEASE COMBINED WITH TYPE 2 DIABETES
by: Z. V. BITAROVA, et al.
Published: (2017-09-01)

Effects of chronic airway obstruction and atrial fibrillation on the cardiac structure and function in patients with heart failure
by: A. I. Chesnikova, et al.
Published: (2020-03-01)

Impact of the angiotensin receptor-neprilysin inhibitor on chronic heart failure due to adult congenital heart disease: A systematic review and meta-analysis
by: Bibhuti B. Das, MD, MBA, MHA, et al.
Published: (2025-05-01)

PREDICTIVE VALUE OF CARDIAC CACHEXIA IN CHRONIC HEART FAILURE
by: E. S. Drobysheva, et al.
Published: (2016-08-01)

Conduction System Pacing for Heart Failure
by: Nathan R. Smith, MD, et al.
Published: (2024-12-01)

Editorial: Cardiac reverse remodeling after novel heart failure therapies—volume II
by: Christian Basile, et al.
Published: (2025-01-01)

Optimization of Renin-Angiotensin-Aldosterone Inhibitor Therapies for Evidence-Based Indications: a Call to Action From the Cardio-Kidney Community
by: Roberto Pecoits-Filho, MD, PhD, et al.
Published: (2025-07-01)

Impact of Exercise on Physiological, Biochemical, and Analytical Parameters in Patients with Heart Failure with Reduced Ejection Fraction
by: Francisco Epelde
Published: (2024-12-01)

Heart Failure: A Deficiency of Energy—A Path Yet to Discover and Walk
by: Ioannis Paraskevaidis, et al.
Published: (2024-11-01)

THE POSSIBILITY OF USAGE OF METABOLIC CORRECTION THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND HEART FAILURE
by: I. V. Sergienko, et al.
Published: (2015-12-01)

Transthyretin cardiac amyloid: Broad heart failure phenotypic spectrum and implications for diagnosis
by: Mileydis Alonso, et al.
Published: (2024-12-01)

Features of structural and geometric remodeling of the heart and changes in the diastolic filling of the heart in patients with chronic heart failure of ischemic genesis with preserved left ventricular ejection fraction
by: V. A. Lysenko, et al.
Published: (2021-03-01)

Features of structural and geometric remodeling of the heart and changes in heart diastolic filling in patients with chronic heart failure of ischemic genesis with reduced left ventricular ejection fraction
by: V. A. Lysenko
Published: (2021-02-01)

Pathophysiology of Angiotensin II-Mediated Hypertension, Cardiac Hypertrophy, and Failure: A Perspective from Macrophages
by: Kelly Carter, et al.
Published: (2024-12-01)

Use of angiotensin receptor – neprilysin inhibitors in heart failure: a paradigm shift
by: M. O.E. Irhuma, et al.
Published: (2016-11-01)

Role of the cardiac extracellular matrix in the onset and progression of heart failure
by: N. N. Ilov, et al.
Published: (2021-07-01)

Cardiac Magnetic Resonance in Heart Failure: Diagnostic and Prognostic Assessments
by: Sara Pezzini, et al.
Published: (2025-05-01)

Prediction of 5-year survival in patients with heart failure and implanted cardiac resynchronization therapy devices
by: A. M. Soldatova, et al.
Published: (2021-07-01)

Clinical and demographic characteristics of patients with congestive heart failure and implanted devices for cardiac resynchronization therapy
by: A. M. Soldatova, et al.
Published: (2021-03-01)

Role of balance exercise dynamic stress in rehabilitation of heart failure patients with reduced ejection fraction
by: Hanan Mohamed Ibrahim Elshoura, et al.
Published: (2025-04-01)

Determinants of cardiac output in health and heart failure
by: Ibrahim Ainab, et al.
Published: (2025-05-01)

Comparative Diagnostic Efficacy of HeartLogic and TriageHF Algorithms in Remote Monitoring of Heart Failure: A Cohort Study
by: David Ledesma Oloriz, et al.
Published: (2025-05-01)

EVALUATION CARDIAC RESYNCHRONIZATION THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART FAILURE
by: A. J. Fishman, et al.
Published: (2014-07-01)

The Effect of Angiotensin Receptor and Neprilysin Inhibitors on Quality of Life in Patients with Heart Failure with Reduced Ejection Fraction and Functional Mitral Regurgitation
by: A. S. Ryazanov, et al.
Published: (2023-01-01)

Pediatric Heart Failure: A Practical Guide to Diagnosis and Management
by: Daniele Masarone, et al.
Published: (2017-08-01)

Features of cardiac remodeling and GDF 15 and NTproBNP levels in patients with heart failure and preserved ejection fraction depending on the history of myocardial infarction
by: Ya. V. Zemlianyi, et al.
Published: (2024-10-01)

The incidence of frailty and its relationship with long-term survival in patients with heart failure and implanted cardiac resynchronization therapy devices
by: A. M. Soldatova, et al.
Published: (2020-09-01)

Impaired Cardiac Sympathetic Activity Is Associated With Myocardial Remodeling and Established Biomarkers of Heart Failure
by: Luis M. da Silva, et al.
Published: (2024-07-01)

Application of the American Heart Association/American College of Cardiology/Heart Failure Society of America Heart Failure Staging Guidelines in Adults With Chronic Kidney Disease
by: Anna M. Zemke, et al.
Published: (2025-07-01)

THE INFLUENCE OF CARDIAC RESYNCHRONIZING THERAPY ON VEGETATIVE HEART RHYTHM REGULATION IN INDIVIDUALS WITH CONGESTIVE HEART FAILURE
by: V. A. Kuznetsov, et al.
Published: (2014-10-01)

Modulation of Cardiac Contractility – a New Method in the Treatment of Heart Failure
by: A. A. Petrukhina, et al.
Published: (2016-11-01)

Myocardial remodeling in chronic heart failure with overweight and obesity taking into account the levels of total cholesterol and triglycerides
by: P. P. Bidzilya
Published: (2016-12-01)

Methylations in dilated cardiomyopathy and heart failure
by: Cong Qin, et al.
Published: (2025-04-01)